Serdar Güngör

Dr. Serdar Güngör

Medical School, Department of Medical Microbiology, Bilecik University, Bilecik, Turkey (Türkiye)

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2013 in Transfusion and Apheresis Science
Verified
Journal Article
Closed access
BUBerrin Uzun
Berrin Uzun
SGserdar güngör
serdar güngör
MDMustafa Demirci
Mustafa Demirci

25 July 2014 in Mikrobiyoloji Bulteni
Verified
Journal Article
Closed access
BUBerrin Uzun
Berrin Uzun
SGserdar güngör
serdar güngör
BPBayram Pektaş
Bayram Pektaş
AGAyşegül AKSOY GÖKMEN
Ayşegül AKSOY GÖKMEN
EYErkan Yula
Erkan Yula
SKSelçuk Kaya
Selçuk Kaya
<%=header_description %> <%=header_description %>

1 January 2008 in Indian Journal of Medical Microbiology
Verified
Journal Article
Open access
PDF file
IAI Afsar
I Afsar
SGserdar güngör
serdar güngör
ASAg Sener
Ag Sener
SYSg Yurtsever
Sg Yurtsever
Indian J Med Microbiol,Official peer-reviewed publication of Indian Association of Medical Microbiologists

2 June 2022 in Acta Chromatographica
Verified
Journal Article
Open access
PDF file
SGserdar güngör
serdar güngör
IBIbrahim Bulduk
Ibrahim Bulduk
BABeyza Sultan Aydın
Beyza Sultan Aydın
RSRahsan Ilikci Sagkan
Rahsan Ilikci Sagkan
Oseltamivir is an antiviral drug and is used in the treatment of all influenza viruses. It is the most effective antiviral option against all influenza viruses that can infect humans. UV and LC methods have been developed and validated according to ICH guidelines for various parameters like selectivity, linearity, accuracy, precision, LOD and LOQ, robustness for the quantitative determination of oseltamivir in pharmaceutical formulations. LC method has been performed using reverse phase technique on a C-18 column with a mobile phase consisting of 20 mM potassium dihydrogen phosphate solution and acetonitrile (60:40, v/v) at 25 °C. The mobile phase flow rate was 1.2 mL min−1. For the determination of oseltamivir, UV spectrum has been recorded between 200 and 800 nm using methanol as solvent and the wavelength of 215 nm has been selected. Both methods have demonstrated good linearity, precision and recovery. No spectral and chromatographic interferences from the capsule excipients were found in UV and LC methods. In both methods, correlation coefficients were greater than 0.999 within a concentration range of 10–60 mg mL−1 using UV and LC. Intra-day and inter-day precision with low relative standard deviation values were observed. The accuracy of these methods was within the range 99.85–100.17% for LC and from 99.26 to 100.70% for UV. Therefore UV and LC methods gave the most reliable outcomes for the determination of oseltamivir in pharmaceutical formulation.

6 February 2023 in Bulletin of the National Research Centre
Verified
Journal Article
Open access
PDF file
AAAhmed Badri Abed
Ahmed Badri Abed
EKElif Korcan
Elif Korcan
SGserdar güngör
serdar güngör
Background: Acinetobacter baumannii is recognized as a major threat that causes healthcare-associated infections and causes a huge challenge to the health system worldwide. This research study was designed to detect the types and profiles of antibiotics tested against A. baumannii clinical strains in Turkey to evaluate their effectiveness and reevaluate their usage. Main body of the The study depended on data search strategy using the online electronic database. We carried out a detailed analysis to all original research articles from 2011 to 2022 all conducted in Turkey. The study involved 91 articles and revealed about 40 antibiotics tested from 2006 to 2021 against A. baumannii with a different frequency. The more frequency antibiotics tested by health institutions in Turkey during this period included 15 antibiotics which are (Amikacin, Gentamicin, Imipenem, Meropenem, Cefoperazone–sulbactam, Ceftazidime, Cefepime, Ampicillin/sulbactam, Piperacillin, Piperacillin/tazobactam, Ciprofloxacin, Levofloxacin, Trimethoprim–Sulfamethoxazole, Colistin and Tigecycline). The frequency of resistance rate with percentage of (80–100%) shown by A. baumannii against these antibiotics was as follows (40.96%, 50.64%, 77.77%, 78.31%, 46.15%, 94.11%, 88.23%, 80.85%, 95.46%, 91.93%, 93.42%, 82.85%, 53.57%, 2.66%, 3.70%), respectively. From 2016 to 2021, an increase in resistance rates by A. baumannii against Colistin and Tigecycline was indicated noticeably. The 0% resistance rates during this period against Colistin were reported in a percentage of 16.6%, while the appearance of highly noticeable resistance (from 80 to 100 = 3.70%) against Tigecycline and the continuous elevation of resistance rates against this drug was worrisome. Short conclusion: Stability in high resistance rates against some antibiotics for the last 10 years and the increase in resistance rates against effective antibiotics by A. baumannii should undergo for more studies and re-evaluation.

1 January 2017 in Medeniyet Medical Journal
Verified
Journal Article
Open access
PSPınar Sen
Pınar Sen
TDTuna Demirdal
Tuna Demirdal
RÖRahim Özdemir
Rahim Özdemir
SNSalih Atakan Nemli
Salih Atakan Nemli
NBNurten Baran
Nurten Baran
SGserdar güngör
serdar güngör